Jiangsu Medical Science and Technology Award, Second Prize (2019): Research on the immunopathogenesis and clinical relevance of chronic hepatitis B
Nanjing Municipal Science and Technology Progress Award, First Prize (2016): Research on the immunoregulatory mechanism of chronic hepatitis B patients and its application in treatment
Jiangsu Provincial Health Department Medical New Technology Introduction Award, First Prize (2013): Clinical application of peripheral blood B cell activation and anti-HBV
Jiangsu Provincial Health Department Medical New Technology Introduction Award, Second Prize (2012): Flow cytometry detection of PD-1 expression on peripheral blood T cells for assessing immune status and antiviral efficacy in chronic hepatitis B patients
Research
Immunoregulatory mechanisms of viral hepatitis and liver fibrosis Immunopathogenesis of emerging infectious diseases
A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China, Rui Huang, Juan Xia, Yuxin Chen, Chun Shan, Chao Wu, 2020
Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac, Chen Y, Shen H, Huang R, Tong X, Wu C, 2021
Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment, Xia J, Huang R, Chen Y, Liu Y, Wang J, Yan X, Zhang Z, Wu C, 2020
Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination, Chen Y, Zhu L, Huang W, Tong X, Wu H, Tao Y, Tong B, Huang H, Chen J, Zhao X, Lou Y, Wu C, 2021
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients, Chen Y, Tong X, Li Y, Gu B, Yan J, Liu Y, Shen H, Huang R, Wu C, 2020
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study, Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, Zhang B, Xu T, Ji F, Zhao Y, Cheng J, Wang Y, Shao H, Hong S, Cao Q, Li C, Zhao XA, Zou L, Sang D, Zhao H, Guan X, Chen X, Shan C, Xia J, Chen Y, Yan X, Wei J, Zhu C, Wu C, 2020
Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment, Zhao XA, Wang J, Liu J, Chen G, Yan X, Jia B, Yang Y, Liu Y, Gu D, Zhang Z, Xiang X, Huang R, Wu C, 2021
Clinical features of COVID-19 patients with non-alcoholic fatty liver disease, Huang R, Zhu L, Wang J, Xue L, Liu L, Yan X, Huang S, Li Y, Yan X, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Wang Y, Zhao H, Hong S, Chen K, Zhao XA, Zou L, Sang D, Shao H, Guan X, Chen X, Chen Y, Wei J, Zhu C, Wu C, 2020
Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis, Liu J, Wang J, Yan X, Xue R, Zhan J, Jiang S, Geng Y, Liu Y, Mao M, Xia J, Yin S, Tong X, Chen Y, Ding W, Huang R, Wu C, 2022
Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID-19, Wang J, Zhu L, Liu L, Zhao XA, Zhang Z, Xue L, Yan X, Huang S, Li Y, Cheng J, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Shao H, Sang D, Zhao H, Guan X, Chen X, Chen Y, Issa R, Wei J, Huang R, Zhu C, Wu C, 2020
Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone, Yao K, Liu J, Wang J, Yan X, Xia J, Yang Y, Wu W, Liu Y, Chen Y, Zhang Z, Li J, Huang R, Wu C, 2021
Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: a retrospective, multi-center study, Wang J, Zhu L, Xue L, Liu L, Yan X, Yan X, Huang S, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Shao H, Chen K, Zhao XA, Sang D, Zhao H, Guan X, Chen X, Chen Y, Liu J, Huang R, Zhu C, Wu C, 2021
Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study, Huang R, Zhu L, Xue L, Yan X, Wang J, Huang S, Zhang B, Xu T, Ji F, Li C, Ming F, Zhao Y, Li Y, Cheng J, Wang Y, Shao H, Hong S, Chen K, Zhao XA, Sang D, Zou L, Zhao H, Guan X, Chen X, Xu B, Xia J, Chen Y, Yan X, Wei J, Liu J, Liu L, Zhu C, Wu C, 2021
A case series of COVID-19 patients with chronic hepatitis B virus infection, Li Y, Li C, Wang J, Zhu C, Zhu L, Ji F, Liu L, Xu T, Zhang B, Xue L, Yan X, Huang R, Wu C, Yan X, 2020
Hepatitis B virus-induced hyperactivation of B cells in chronic hepatitis B patients via TLR4, Li Y, Yin S, Chen Y, Zhang Q, Huang R, Jia B, Jie W, Yao K, Wang J, Tong X, Liu Y, Wu C, 2020
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B, Huang R, Liu J, Wang J, Yan X, Wu C, 2021
Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis, Huang R, Liu J, Wang J, Wu C, 2021
Letter to the Editor: Is hepatitis B virus genotype strongly associated with hepatocellular carcinoma risk in patients with chronic hepatitis B?, Huang R, Liu J, Wang J, Li J, Wu C, 2022
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis, Huang R, Liu J, Wang J, Wu C, 2021
Clinical characteristics of a case series of children with coronavirus disease 2019, Zhu L, Wang J, Huang R, Liu L, Zhao H, Wu C, Zhu C, 2020
High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients, Chen Y, Tong X, Wang J, Huang W, Yin S, Huang R, Yang H, Chen Y, Huang A, Liu Y, Chen Y, Yuan L, Yan X, Shen H, Wu C, 2020
Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B, Huang R, Wang J, Zhang Z, Yan X, Wu C, 2020
Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B, Huang R, Wang J, Wu W, Yan X, Wu C, 2020
A family cluster of COVID-19 involving an asymptomatic case with persistently positive SARS-CoV-2 in anal swabs, Huang R, Zhao H, Wang J, Yan X, Shao H, Wu C, 2020
Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B, Wang J, Xia J, Yan X, Yang Y, Wei J, Xiong Y, Wu W, Liu Y, Chen Y, Jia B, Chen Z, Zhang Z, Ding W, Huang R, Wu C, 2020
Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China, Chang H, Wei J, Zhou W, Yan X, Cao X, Zuo L, Chen S, Yao K, Huang R, Chen Y, Wu C, 2020
HBeAg Negativity Is Associated With More Advanced Liver Fibrosis in Patients With Chronic Hepatitis B: A Propensity Score-Matching Analysis, Wang J, Wu W, Yan X, Wei J, Yao K, Yang Y, Xiong Y, Xia J, Liu Y, Chen Y, Jia B, Zhang Z, Ding W, Huang R, Wu C, 2020
Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans, Tian C, Chen Y, Liu Y, Wang S, Li Y, Wang G, Xia J, Zhao XA, Huang R, Lu S, Wu C, 2018
Area of Focus
Arrhythmia | Cardiovascular | Big Data | Clinical Research | Database | Machine Learning | Covid-19 | Epidemiology | Electrophysiology | Thrombus
